Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation

Background: Traumatic brain injury (TBI) is a leading cause of mortality worldwide and often results in substantial cognitive, motor, and psychological impairments, triggering oxidative stress, neuroinflammation, and neurodegeneration. This study examined the neuroprotective effects of azithromycin...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohannad A. Almikhlafi, Nehad A. Abdallah, Aakash Kumar, Tarun Sharma, Zuber Khan, Haifa A. Fadil, Sultan Althagfan, Ahmed K. B. Aljohani, Sara A. Almadani, Samar F. Miski, Tahani Saeedi, Rayan S. Alharbi, Abdulrahman M. Al-Harthe, Mohammed H. Alsubhi, Hanaa Wanas, Ahmed Aldhafiri, Sidharth Mehan, Hossein M. Elbadawy
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/1/115
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587722225614848
author Mohannad A. Almikhlafi
Nehad A. Abdallah
Aakash Kumar
Tarun Sharma
Zuber Khan
Haifa A. Fadil
Sultan Althagfan
Ahmed K. B. Aljohani
Sara A. Almadani
Samar F. Miski
Tahani Saeedi
Rayan S. Alharbi
Abdulrahman M. Al-Harthe
Mohammed H. Alsubhi
Hanaa Wanas
Ahmed Aldhafiri
Sidharth Mehan
Hossein M. Elbadawy
author_facet Mohannad A. Almikhlafi
Nehad A. Abdallah
Aakash Kumar
Tarun Sharma
Zuber Khan
Haifa A. Fadil
Sultan Althagfan
Ahmed K. B. Aljohani
Sara A. Almadani
Samar F. Miski
Tahani Saeedi
Rayan S. Alharbi
Abdulrahman M. Al-Harthe
Mohammed H. Alsubhi
Hanaa Wanas
Ahmed Aldhafiri
Sidharth Mehan
Hossein M. Elbadawy
author_sort Mohannad A. Almikhlafi
collection DOAJ
description Background: Traumatic brain injury (TBI) is a leading cause of mortality worldwide and often results in substantial cognitive, motor, and psychological impairments, triggering oxidative stress, neuroinflammation, and neurodegeneration. This study examined the neuroprotective effects of azithromycin (AZI) in TBI. Methods: TBI was induced in rats using the weight-drop method. Subsequently, rats received a daily intraperitoneal (I.P.) dose of AZI (150 mg/kg) for 28 days. Behavioral tests (Morris water maze, rotarod, and open field tests) were performed to assess cognitive and motor functions. Neurochemical analyses included oxidative stress markers (GSH, SOD, MDA, catalase), inflammatory cytokines (TNF-α, IL-1β), apoptotic markers (caspase-3, Bax, Bcl-2), mitochondrial complexes (complex I, II, III, IV, and V), and the transforming growth factor- beta (TGF-β) as a neurofilament marker. Histological evaluations focused on neuronal integrity in the cortex, hippocampus, and striatum. Results: Treatment with AZI significantly facilitated motor and cognitive function recovery in TBI-affected rats. At the molecular level, AZI effectively reduced oxidative stress markers, ameliorated neuroinflammation by decreasing TNF-α, IL-1β, and neuronal apoptosis, and differentially modulated mitochondrial complexes. Histological assessments revealed enhanced neuronal integrity and fewer pathological changes in AZI-treated rats compared to untreated TBI controls. Conclusions: AZI was shown to interfere with several pathways involved in TBI’s pathophysiology. While preclinical results are promising, further studies are necessary to establish the long-term safety and efficacy of AZI in a clinical setting. This research supports the potential re-purposing of AZI as a novel treatment strategy for TBI and related neurodegenerative disorders.
format Article
id doaj-art-8a11734dc8e840309bd0fd3aac08a67c
institution Kabale University
issn 1424-8247
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-8a11734dc8e840309bd0fd3aac08a67c2025-01-24T13:45:27ZengMDPI AGPharmaceuticals1424-82472025-01-0118111510.3390/ph18010115Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory ModulationMohannad A. Almikhlafi0Nehad A. Abdallah1Aakash Kumar2Tarun Sharma3Zuber Khan4Haifa A. Fadil5Sultan Althagfan6Ahmed K. B. Aljohani7Sara A. Almadani8Samar F. Miski9Tahani Saeedi10Rayan S. Alharbi11Abdulrahman M. Al-Harthe12Mohammed H. Alsubhi13Hanaa Wanas14Ahmed Aldhafiri15Sidharth Mehan16Hossein M. Elbadawy17Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDivision of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, IK Gujral Punjab Technical University, Jalandhar 144603, Punjab, IndiaDivision of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, IK Gujral Punjab Technical University, Jalandhar 144603, Punjab, IndiaDivision of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, IK Gujral Punjab Technical University, Jalandhar 144603, Punjab, IndiaDepartment of Pharmacy Practice, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacy Practice, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaDivision of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, IK Gujral Punjab Technical University, Jalandhar 144603, Punjab, IndiaDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi ArabiaBackground: Traumatic brain injury (TBI) is a leading cause of mortality worldwide and often results in substantial cognitive, motor, and psychological impairments, triggering oxidative stress, neuroinflammation, and neurodegeneration. This study examined the neuroprotective effects of azithromycin (AZI) in TBI. Methods: TBI was induced in rats using the weight-drop method. Subsequently, rats received a daily intraperitoneal (I.P.) dose of AZI (150 mg/kg) for 28 days. Behavioral tests (Morris water maze, rotarod, and open field tests) were performed to assess cognitive and motor functions. Neurochemical analyses included oxidative stress markers (GSH, SOD, MDA, catalase), inflammatory cytokines (TNF-α, IL-1β), apoptotic markers (caspase-3, Bax, Bcl-2), mitochondrial complexes (complex I, II, III, IV, and V), and the transforming growth factor- beta (TGF-β) as a neurofilament marker. Histological evaluations focused on neuronal integrity in the cortex, hippocampus, and striatum. Results: Treatment with AZI significantly facilitated motor and cognitive function recovery in TBI-affected rats. At the molecular level, AZI effectively reduced oxidative stress markers, ameliorated neuroinflammation by decreasing TNF-α, IL-1β, and neuronal apoptosis, and differentially modulated mitochondrial complexes. Histological assessments revealed enhanced neuronal integrity and fewer pathological changes in AZI-treated rats compared to untreated TBI controls. Conclusions: AZI was shown to interfere with several pathways involved in TBI’s pathophysiology. While preclinical results are promising, further studies are necessary to establish the long-term safety and efficacy of AZI in a clinical setting. This research supports the potential re-purposing of AZI as a novel treatment strategy for TBI and related neurodegenerative disorders.https://www.mdpi.com/1424-8247/18/1/115azithromycintraumatic brain injuryneuroprotection
spellingShingle Mohannad A. Almikhlafi
Nehad A. Abdallah
Aakash Kumar
Tarun Sharma
Zuber Khan
Haifa A. Fadil
Sultan Althagfan
Ahmed K. B. Aljohani
Sara A. Almadani
Samar F. Miski
Tahani Saeedi
Rayan S. Alharbi
Abdulrahman M. Al-Harthe
Mohammed H. Alsubhi
Hanaa Wanas
Ahmed Aldhafiri
Sidharth Mehan
Hossein M. Elbadawy
Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
Pharmaceuticals
azithromycin
traumatic brain injury
neuroprotection
title Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
title_full Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
title_fullStr Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
title_full_unstemmed Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
title_short Exploring Azithromycin’s Neuroprotective Role in Traumatic Brain Injury: Insights into Cognitive and Motor Recovery and Neuroinflammatory Modulation
title_sort exploring azithromycin s neuroprotective role in traumatic brain injury insights into cognitive and motor recovery and neuroinflammatory modulation
topic azithromycin
traumatic brain injury
neuroprotection
url https://www.mdpi.com/1424-8247/18/1/115
work_keys_str_mv AT mohannadaalmikhlafi exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT nehadaabdallah exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT aakashkumar exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT tarunsharma exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT zuberkhan exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT haifaafadil exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT sultanalthagfan exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT ahmedkbaljohani exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT saraaalmadani exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT samarfmiski exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT tahanisaeedi exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT rayansalharbi exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT abdulrahmanmalharthe exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT mohammedhalsubhi exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT hanaawanas exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT ahmedaldhafiri exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT sidharthmehan exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation
AT hosseinmelbadawy exploringazithromycinsneuroprotectiveroleintraumaticbraininjuryinsightsintocognitiveandmotorrecoveryandneuroinflammatorymodulation